Literature DB >> 31317523

Physical exercise improves functional capacity and quality of life in patients with acromegaly: a 12-week follow-up study.

Tatiana Rafaela Lemos Lima1, Leandro Kasuki2,3, Monica Gadelha2,3, Agnaldo José Lopes4,5.   

Abstract

OBJECTIVE: Although the focus of acromegaly treatment is the hormonal control of the disease, a new perspective must be given to the functional rehabilitation of these patients, especially when considering the recent increase in survival. The aim of this study was to evaluate the effects of therapist-oriented home rehabilitation (TOHR) on patients with acromegaly. PATIENTS AND METHODS: Seventeen adults with acromegaly followed an exercise programme from a booklet with instructions for each exercise prescribed, for 2 months, and were reassessed after 1 month of washout. At each of the 3 timepoints (before and after the intervention and at the 1-month follow-up), the participants were subjected to the following assessments: body composition through bioimpedance, health-related quality of life (HRQoL) using the Acromegaly Quality of Life (AcroQoL) questionnaire, general fatigue through the Functional Assessment of Chronic Illness Therapy-Fatigue scale, handgrip strength, lower extremity functionality using isometric dynamometry and the Lower Extremity Functional Scale (LEFS), body balance through stabilometry, and functional capacity through 6-minute walking distance (6MWD).
RESULTS: After performing TOHR, improvements in general fatigue, quadriceps muscle strength, LEFS, 6MWD, balance control and all AcroQoL dimensions were observed (all P < 0.05). After 1 month of washout, however, these gains were lost for all parameters, except the LEFS and balance control.
CONCLUSIONS: In acromegaly, TOHR results in improvements in muscle function, functional capacity, general fatigue, body balance, and HRQoL. Large randomized controlled trials are needed to replicate these benefits and to recommend rehabilitation, especially for those with long-term illness.

Entities:  

Keywords:  Acromegaly; Exercise; Muscles; Quality of life; Rehabilitation

Mesh:

Year:  2019        PMID: 31317523     DOI: 10.1007/s12020-019-02011-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  36 in total

Review 1.  The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.

Authors:  Linda J Woodhouse; Annice Mukherjee; Stephen M Shalet; Shereen Ezzat
Journal:  Endocr Rev       Date:  2006-03-16       Impact factor: 19.871

2.  Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly.

Authors:  Jitske Tiemensma; Adrian A Kaptein; Alberto M Pereira; Johannes W A Smit; Johannes A Romijn; Nienke R Biermasz
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

3.  Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study.

Authors:  Nikolaos Kyriakakis; Julie Lynch; Stephen G Gilbey; Susan M Webb; Robert D Murray
Journal:  Clin Endocrinol (Oxf)       Date:  2017-04-18       Impact factor: 3.478

4.  Perception of health and cognitive dysfunction in acromegaly patients.

Authors:  Iris Crespo; Susan M Webb
Journal:  Endocrine       Date:  2014-03-25       Impact factor: 3.633

5.  Balance is impaired in people with chronic obstructive pulmonary disease.

Authors:  Michelle D Smith; Angela T Chang; Helen E Seale; James R Walsh; Paul W Hodges
Journal:  Gait Posture       Date:  2010-03-04       Impact factor: 2.840

6.  Physical and cardiovascular performance in cases with acromegaly after regular short-term exercise.

Authors:  Esra Hatipoglu; Nuri Topsakal; Oya Erkut Atilgan; Asiye Filiz Camliguney; Baris Ikitimur; Serdal Ugurlu; Mutlu Niyazoglu; Hasan Birol Cotuk; Pinar Kadioglu
Journal:  Clin Endocrinol (Oxf)       Date:  2015-02-06       Impact factor: 3.478

7.  Acromegaly: an endocrine society clinical practice guideline.

Authors:  Laurence Katznelson; Edward R Laws; Shlomo Melmed; Mark E Molitch; Mohammad Hassan Murad; Andrea Utz; John A H Wass
Journal:  J Clin Endocrinol Metab       Date:  2014-10-30       Impact factor: 5.958

8.  Ventilation threshold as a measure of impaired physical performance in adults with growth hormone excess.

Authors:  Scott G Thomas; Linda J Woodhouse; Sonia M Pagura; Shereen Ezzat
Journal:  Clin Endocrinol (Oxf)       Date:  2002-03       Impact factor: 3.478

Review 9.  Systemic complications of acromegaly: epidemiology, pathogenesis, and management.

Authors:  Annamaria Colao; Diego Ferone; Paolo Marzullo; Gaetano Lombardi
Journal:  Endocr Rev       Date:  2004-02       Impact factor: 19.871

10.  The effects of isolated ankle strengthening and functional balance training on strength, running mechanics, postural control and injury prevention in novice runners: design of a randomized controlled trial.

Authors:  Jennifer Baltich; Carolyn A Emery; Darren Stefanyshyn; Benno M Nigg
Journal:  BMC Musculoskelet Disord       Date:  2014-12-04       Impact factor: 2.362

View more
  4 in total

1.  Can home rehabilitation impact impulse oscillometry and lung ultrasound findings in patients with scleroderma-associated interstitial lung disease? A pilot study.

Authors:  Samantha Gomes de Alegria; Patrícia Frascari Litrento; Iasmim de Oliveira Farias; Thiago Thomaz Mafort; Agnaldo José Lopes
Journal:  BMC Res Notes       Date:  2022-05-15

Review 2.  GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice.

Authors:  Betina Biagetti; Rafael Simó
Journal:  Int J Mol Sci       Date:  2021-01-02       Impact factor: 5.923

3.  Postural balance and its association with functionality and quality of life in non-hospitalized patients with post-acute COVID-19 syndrome.

Authors:  Kennedy Cristian Alves de Sousa; Damara Guedes Gardel; Agnaldo José Lopes
Journal:  Physiother Res Int       Date:  2022-07-17

Review 4.  Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management.

Authors:  P Maffei; F Dassie; S Camerini; A Wennberg; M Adriani; B Martin; R Vettor
Journal:  J Endocrinol Invest       Date:  2022-03-23       Impact factor: 5.467

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.